Pearl Pathways is celebrating 5 years of being in business. We are excited to celebrate these fantastic years and want you to join us! Appetizers and refreshments will be served throughout the evening. When: August 6th, 2015 Time: 4:30pm-7:00pm Where: 29 E McCarty...
Every so often, clinical tries are said to ‘fail’, but can the trial actually fail? According to John Lechleiter, President and CEO of Eli Lilly and Company, “a clinical trial is a failure only if we can’t learn from it.” He believes that no matter how a clinical...
Recently, Cedars-Sinai “Research for Her” advanced its clinical research study participation registry matching women with research studies and clinical trials. The results included more participants and reduced registration time compared to paper based processes. “A...
Enrollment barriers to secure patients for genomically matched trials still challenge the discovery for molecular cancer therapies; however , help may be on the way. Only a few patients who have gene alterations are selected to participate in genomically matched...
Many companies are hesitant to perform clinical studies on children due to the risks and ethical issues that can arise. This is why the European Medicines Agency (EMA) is looking into revising and reforming the product class waivers to allow companies to test new...
